S100A9 and neoplasm: S100A9 knockout mice, which are deficient in their ability to accumulate MDSCs in tumor-bearing hosts, showed significantly reduced MDSC accumulation in the bone marrow along with significant accumulation of tumor-specific CD8+ cells, suggesting a possible CD8+-specific effect of MDSCs (70).